Regarding the three clinical phases (NC, MCI, and AD), HMGCR mainly acts during the MCI stage, where it may also impact brain glucose metabolism [89,90] and contribute to the pathophysiological transition from MCI to AD [90,91]. The gene discussed is HMGCR; the disease is Alzheimer disease.